SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : Value Investing -- Ignore unavailable to you. Want to Upgrade?


To: Paul Senior who wrote (25833)1/27/2007 12:23:02 AM
From: a128  Respond to of 78732
 
Hey, we NEED IBD folks so we can sell at OVERvalued prices.

God forbid if some of my winners stopped going up at fair value !



To: Paul Senior who wrote (25833)1/27/2007 12:30:54 AM
From: Carl Worth  Read Replies (1) | Respond to of 78732
 
IBD has sort of made itself into its own joke IMHO

they state that you shouldn't buy a stock under 15 bucks because supposedly quality stocks don't trade with a price under 15...then every few weeks they publish "the 10 best stocks under 10 bucks"

they publish the IBD 100, and UCTT shows up one week near the top, then the next week it is completely out, because the price went over 15 for one week, then back below

while they have some good ideas on capital preservation and owning the leaders in a particular sector, if anyone followed their guidelines to a T, i think they would have trouble making consistent profits unless every year was like 2003, or the tech bubble days



To: Paul Senior who wrote (25833)1/27/2007 4:56:42 AM
From: John Carragher  Respond to of 78732
 
quite a few of the articles years ago used to be guest articles. fillers so to speak. ibd didn't really have a staff that did analysis etc. I remember one time taking trial subscription and getting called from customer service at ibd about signing up for paper. i told them no i was disappointed in the articles. It appear to be more pr articles written by small companies to get some press. He agreed many articles are just that.



To: Paul Senior who wrote (25833)1/27/2007 9:08:24 AM
From: anializer  Read Replies (1) | Respond to of 78732
 
Like Carl said, most investors would be losers if they employed the IBD strategy to a T. Sure, a glance at the IBD 100 and 100 charts would make one feel incompetent, but they are resultant charts based on prior action, not hand picked stocks. The Cup and Handle w/the CANSLIM method has only been useful when a Value stock exhibits those chart pattern characteristics. Buying stocks at 50 to 100 PE ratios 20X book just because they have been going up in the past will almost always result in damage. That said, the paper has some value for its database and wide coverage of stocks. The Wall St. Journal in turn as a daily has too much advertising and not enough stock meat. More often than not, an IBD article published on a stock is known as the kiss of death quite accurately.